Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Heart Failure Association of the European Society of Cardiology (ESC-HFA)
June 29 - July 01, 2021; Virtual
June 29 - July 01, 2021Virtual
ESC-HFA 2021Assays May Guide SGLT2 Inhibitor Use in High CV-Risk DiabetesNot all with diabetes at heightened cardiovascular risk may benefit from some of these drugs, so how to choose? And through what mechanisms do SGLT2 inhibitors cut CV risk, anyway?
Ablation Lessens AF Burden Along With Recurrence Risk: CABANAThe burden of atrial fibrillation by Holter fell sharply 5 years after cath ablation, even for a subgroup that doesn't often
respond well, in a prespecified secondary analysis of the trial.
Medscape Medical News, Jun 24, 2020
Vericiguat Success in HFrEF May Not Apply to Sickest: VICTORIANatriuretic peptide levels may have forecast who would benefit on the novel agent vs who might be more appropriate for 'nonpharmacological
treatment or palliative care,' said an expert observer.
